BIG DEAL: Drug, device and health products maker Johnson & Johnson says it will wrap up its biggest deal ever Thursday, a $19.7 billion purchase of Swiss orthopedic products maker Synthes.

STRATEGIC MOVE: J&J is aiming for a dominant position in the growing orthopedics surgery market by gaining the strong trauma surgery products business of Synthes and expanding that company in emerging markets such as China and India.